- Home
- FTCI vs CLSD Comparison
FTCI vs CLSD Comparison
Compare FTCI & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTCI
- CLSD
- Stock Information
- Founded
- FTCI 2017
- CLSD 2011
- Country
- FTCI United States
- CLSD United States
- Employees
- FTCI N/A
- CLSD N/A
- Industry
- FTCI Semiconductors
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- FTCI Technology
- CLSD Health Care
- Exchange
- FTCI Nasdaq
- CLSD Nasdaq
- Market Cap
- FTCI 58.9M
- CLSD 59.1M
- IPO Year
- FTCI 2021
- CLSD 2016
- Fundamental
- Price
- FTCI $5.13
- CLSD $0.87
- Analyst Decision
- FTCI Buy
- CLSD Strong Buy
- Analyst Count
- FTCI 4
- CLSD 4
- Target Price
- FTCI $5.50
- CLSD $4.75
- AVG Volume (30 Days)
- FTCI 95.0K
- CLSD 179.1K
- Earning Date
- FTCI 08-07-2025
- CLSD 08-11-2025
- Dividend Yield
- FTCI N/A
- CLSD N/A
- EPS Growth
- FTCI N/A
- CLSD N/A
- EPS
- FTCI N/A
- CLSD N/A
- Revenue
- FTCI $55,571,000.00
- CLSD $3,764,000.00
- Revenue This Year
- FTCI $102.41
- CLSD $60.52
- Revenue Next Year
- FTCI $154.53
- CLSD $88.28
- P/E Ratio
- FTCI N/A
- CLSD N/A
- Revenue Growth
- FTCI N/A
- CLSD N/A
- 52 Week Low
- FTCI $1.76
- CLSD $0.70
- 52 Week High
- FTCI $7.40
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- FTCI 66.90
- CLSD 58.96
- Support Level
- FTCI $4.92
- CLSD $0.80
- Resistance Level
- FTCI $5.25
- CLSD $0.88
- Average True Range (ATR)
- FTCI 0.35
- CLSD 0.04
- MACD
- FTCI 0.04
- CLSD 0.01
- Stochastic Oscillator
- FTCI 89.58
- CLSD 84.82
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.